Ategrity Specialty Insurance Co., a provider of excess and surplus insurance to small and midsize US companies, is exploring ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $145.0 to $272.5 for JPMorgan Chase over the last 3 months.

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and ...

J.P. Morgan analyst Kenneth Worthington on Wednesday downgraded Federated Hermes (FHI) shares to Underweight from ...

In a report released today, Chris Schott from J.P. Morgan maintained a Buy rating on Merck & Company (MRK – Research Report), with a price ...

Spring is upon the United States stock market yet again. During this time, a particular set of stocks, mostly concentrated in ...

Private-equity firm Thoma Bravo taking company public at an estimated market cap of $11 billion in its return to the stock ...

Maze Therapeutics, a clinical-stage biopharmaceutical company, launched its initial public offering (IPO) today, with shares ...

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, ...

We recently compiled a list of the 10 Extreme Dividend Stocks to Invest in Now. In this article, we are going to take a look ...

Ascentage Pharma Group (AAPG) (AAPGV) (ASPHF), which is backed by Takeda (TAK), has priced a $126M U.S. initial public offering. Read more here.